Filing Details
- Accession Number:
- 0000899866-13-000197
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-11 20:57:09
- Reporting Period:
- 2012-03-05
- Filing Date:
- 2013-12-11
- Accepted Time:
- 2013-12-11 20:57:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231950 | S Alvin Parven | C/O Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire CT 06410 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | Acquisiton | 2012-03-05 | 140 | $84.95 | 7,451 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On June 8, 2012, the Reporting Person sold 30,000 shares of common stock at a weighted average price of $91.01 per share ($91.07 was the highest price at which such shares were sold). Such sale was within six months of the Reporting Person's acquisition of the 140 shares of common stock reported on this Form 4 and at a price higher than the Reporting Person's purchase price. Accordingly, the Reporting Person paid the company $858.60 in short-swing profits under Section 16(b).
Billionaire Hedge Funds
